TransMedics (TMDX) EBIAT (2018 - 2025)
Historic EBIAT for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $24.3 million.
- TransMedics' EBIAT rose 47682.64% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.8 million, marking a year-over-year increase of 18127.03%. This contributed to the annual value of $35.5 million for FY2024, which is 24184.11% up from last year.
- TransMedics' EBIAT amounted to $24.3 million in Q3 2025, which was up 47682.64% from $34.9 million recorded in Q2 2025.
- In the past 5 years, TransMedics' EBIAT ranged from a high of $34.9 million in Q2 2025 and a low of -$25.4 million during Q3 2023
- For the 5-year period, TransMedics' EBIAT averaged around $786000.0, with its median value being -$2.6 million (2023).
- Per our database at Business Quant, TransMedics' EBIAT crashed by 24233.77% in 2023 and then soared by 131818.18% in 2024.
- Over the past 5 years, TransMedics' EBIAT (Quarter) stood at -$12.7 million in 2021, then surged by 46.95% to -$6.7 million in 2022, then skyrocketed by 159.99% to $4.0 million in 2023, then soared by 71.0% to $6.9 million in 2024, then skyrocketed by 252.81% to $24.3 million in 2025.
- Its last three reported values are $24.3 million in Q3 2025, $34.9 million for Q2 2025, and $25.7 million during Q1 2025.